Industry News
Pharmaceutical Industry News
Gilead Sciences has struck accords…
Gilead Sciences has struck accords with Lupin, Cipla and Laurus Labs to delay the entry of any Biktarvy copycats in the U.S. until April 1, 2036. Gilead had previously estimated that Biktarvy’s U.S. market exclusivity
Even as President Donald Trump…
Even as President Donald Trump directed the FDA in early September to begin cracking down on direct-to-consumer pharmaceutical advertising, spending on TV drug ads still ratcheted up compared to the preceding few months.
The CDC’s updated COVID guidelines…
The CDC's updated COVID guidelines put the vaccines under an individual-based decision-making practice as opposed to the agency's prior universal recommendation.
A California judge has ruled that…
A California judge has ruled that Biogen owes Roche $124 million in royalties for its use of intellectual property developed more than 40 years ago by the Swiss company’s subsidiary Genentech that covered a process
Peter Stark says quality projected…
Peter Stark says quality projected data drives accurate forecasting, better engagement and earlier diagnoses
Vice president of strategy…
Vice president of strategy outlines key considerations for data and go-to-market strategies
Amgen has joined the wave of major…
Amgen has joined the wave of major drugmakers setting up direct-to-consumer programs amid President Donald Trump’s call for more DTC options to lower U.S. drug prices.
The company will work with new…
The company will work with new local contract manufacturers in India to boost supply of its key medicines.
AstraZeneca and Daiichi Sankyo’s…
AstraZeneca and Daiichi Sankyo’s Datroway has become the first cancer drug to show an overall survival benefit against chemotherapy for certain patients with a particularly aggressive form of breast cancer. In a phase 3 trial,
Myeloid Therapeutics’ name no…
Myeloid Therapeutics’ name no longer fits its pipeline. Having expanded beyond the eponymous myeloid cells, the biotech has rebranded as Create Medicines and committed to an R&D strategy that spans in vivo multi-immune programming.
What to Know as Gisèle Pelicot Returns to Court for Man’s Appeal
The Frenchwoman who became a feminist icon will confront one of the men convicted after her husband drugged her and invited them to rape her over nearly 10 years.
Costco to Sell Ozempic and Wegovy, Weight-Loss Wonder Drugs
Costco members will pay $499 a month out of pocket, the same price offered at CVS and Walmart, and on the manufacturer’s direct-to-consumer website.
Why Brittle Bones Aren’t Just a Woman’s Problem
More men are now living long enough to develop osteoporosis. But few are aware of the risk, and fewer still are screened and treated.
How Private Equity Oversees the Ethics of Drug Research
Many drug trials are vetted by companies with ties to the drugmakers, raising concerns about conflicts of interest and patient safety.
Rite Aid Closes Its Remaining Stores
The company said it had closed its remaining 89 stores this week after struggling for years to stay in business and filing for bankruptcy protection twice.
Katie Carr of Swoop discusses…
Katie Carr of Swoop discusses evolving privacy laws, TV’s role in patient trust and the future of in-house measurement
The FDA unveiled a new pilot…
The FDA unveiled a new pilot program that aims to speed up review times for generic drugmakers who test and manufacture their products in the U.S. Separately, the agency met with industry stakeholders this week
Patients and providers often enter…
Patients and providers often enter the exam room misaligned. A 360° data strategy may be pharma’s missing link.
OptimizeRx CEO highlights earlier…
OptimizeRx CEO highlights earlier diagnosis, smarter strategies
In a letter inked to the U.K.’s…
In a letter inked to the U.K.’s Competition and Markets Authority, three advocacy organizations called the recent string of Big Pharma companies pulling their U.K. investments a coordinated scheme for "anti-competitive purposes."